Objectives: Metallo-beta lactamase (MBL) producing non fermenter Gram negative bacilli is an emerging warning and cause of worry as they have established as one of the most feared resistance mechanisms and are the foremost cause of nosocomial infections worldwide. Carbapenem, including Imipenem, Meropenem and Doripenem are often used as a last remedy for treatment of infections caused by Pseudomonas aeruginosa, Acinetobacter and other Gram-negative. The present study was designed to explore the distribution of imipenem resistant non-fermenter Gram-negative bacilli isolates in different age groups. Study Design: Cross sectional Descriptive study. Setting: Microbiology laboratory, PGMI, Lahore. Period: January 2015 to December 2015. Material & Methods: 53 imipenem resistant NFGNB that were isolated from appropriate sampling of patients suffering from several infections were analyzed by using different standard microbiological techniques like microscopy, culture methods, biochemical reactions and antibiotic susceptibility using Kirby-Bauer method. MBL recognition was performed by imipenem-2MPA double disc synergy test (DDST). Results: This study shows the frequency of imipenem resistant non-fermenter Gram-negative bacilli isolated from various clinical wards. Maximum NFGNB were recovered from surgery/surgical allied 35.84% followed by ICU 28.3%, medicine /medicine allied 20.75%, pediatrics 9.4% and gynae/ obs 5.6% respectively. MBL production was identified among different imipenem resistant non-fermenter Gram-negative bacilli isolates by DDST using 2-MPA. Out of total 53 imipenem resistant non-fermenter Gram Negative Bacilli 37 Pseudomonas aeruginosa 20(54.05%) were MBL positive. Out of 13 Acinetobacter baumannii and 2 Pseudomonas luteola, 11(84.61%) Acinetobacter baumannii and 1(50%) Pseudomonas luteola were positive for MBL production. None of the Acinetobacter junii indicated MBL production. Conclusion: Double disc synergy test is operational for detection of MBL producers among NFGNB. It can be established in our routine clinical microbiology laboratories, for the MBL recognition especially in imipenem resistant isolates as of its cost efficiency.
INTRODUCTION
Metallo beta lactamase (MBL) producing nonfermenter Gram negative bacilli is an evolving intimidation and cause of terror, as they have established as one of the most dreaded resistance mechanisms and are the prominent cause of nosocomial infections globally. 1 Carbapenem, including imipenem, meropenem and doripenem are often used as a last option for treatment of infections, which caused by Pseudomonas aeruginosa, Acinetobacter and other Gram-negative bacteria. However, carbapenem-resistant P. aeruginosa has become prevalent worldwide. 2 Carbapenem resistance is mainly due to up regulation of efflux pumps, reduced outer membrane permeability. 3 MBLs are reticent by metal chelators, such as an ethylenediamine tetra acetic acid (EDTA) and thiol-based compounds. MBL-encoding genes have been testified worldwide in GNB, such as Pseudomonas spp. Acinetobacter spp, and members of the Enterobacteriaceae family. 4 The non-fermenter Pseudomonas aeruginosa is a well-known dreaded pathogen in hospital surroundings and 5 It is estimated that at least 2 million people gain bacterial infections that are resistant to standard therapy each year only in in the United States. 6 Up to 25% of cutaneous colonization is caused by Acinetobacter and are the most common bacteria found on the skin of hospital personnel, which, often a times, cause a number of outbreaks of nosocomial infections such as septicemia, pneumonia, wound sepsis, endocarditis, meningitis, urinary tract infections. 7 Eventually, infection control specialists and clinical microbiologists need to work together to regulate the risk carried by Carbapenem resistant non fermenting Gram-negative bacilli in their institution and what methods should be measured for surveillance and revealing of these pathogens.
METHODOLOGY
This descriptive study has been conducted in the Microbiology department of Post Graduate Medical Institute from January 2015 to December 2015. All the labeled samples received in microbiology laboratory from Lahore General Hospital were inoculated on Blood agar and MacConkey agar and incubated at 37°C for 24 hours. Non-lactose fermentation was noted on Mac Conkey agar. Preliminary identification of NFGNB was done by Gram staining, Catalase and Oxidase test. The final confirmation of all the NFGNB was done upto specie level by Analytical profile index Non Enterobactericae Kit (API 20 NE Biomerieux). Phenotypic verification of provisional MBL producers was done by Double Disc Synergy Test. Isolates which were imipenem resistant were advance investigated for Metallobeta lactamase production by double disc synergy method. The bacterial suspension with turbidity equivalent to 0.5 Mc Farland standards was arranged and inoculated on Mueller Hinton agar.
After inoculation of the experimental organism on Muller Hinton agar, 2 imipenem disc containing 10 micrograms were positioned on the surface of agar plate at the distance of 4-5 cm center to center. A disc comprising 3 microliters of diluted 1:8 2-Mercaptopropionic acid was placed near one of the IPM disc at a distance of 1-1.5 cm. The plates were incubated at 37˚C overnight. The expansion of the diameter of growth inhibitory zone around imipenem and 1:8 2-Mercaptopropionic containing disc by ≥ 7mm was reflected as positive for MBL production. Quality control of Pseudomonas aeruginosa (ATCC 27853) and Stenotrophomonas maltophilia (ATCC 13636) was run with each batch of the test. The results were interpreted as per Clinical and Laboratory Standard Institute guidelines.
RESULTS
Total 53 imipenem resistant non-fermenter Gramnegative bacilli were isolated for culture and sensitivity during the study period. Positive synergy test is shown in Figure- Acinetobacter Junii (1) 0 0% 
DISCUSSION
Due to excessive and irrational use of carbapenems, a shocking increase in carbapenem resistance has been recounted in many Gramnegative bacteria including Acinetobacter spp. 8 The resistance produced by broad-spectrum cephalosporin is a tenacious problem in managing infections caused by Pseudomonas areuginosa, and Enterobacter species, as well as other Enterobacteriaceae. 9 There are limited treatment options for carbapenem -resistant Acinetobacter baumannii and Enterobacteriaceae, so clinicians must completely evaluate all offered therapeutic options for treating these multidrug-resistant organisms. 10 The present study showed the dispersal of imipenem resistant non-fermenter Gram-negative bacilli isolates according to age. fermenter Gram-negative bacilli 37 (69.81%) were Pseudomonas aeroginosa. Our results were alike with the number of studies such as study carried out chawla et al in 2013; they recounted that Pseudomonas aeruginosa was the most commonly isolated non-fermenter pathogen. 17 In difference to our study, Goel et al in 2013 in tertiary care hospital of India described that Acinetobacter baumannii 48.78% was the chief isolated pathogen among the non-fermenters trailed by Pseudomonas aeruginosa 31.71%. 18 
CONCLUSION
Non-fermenting Gram-negative bacilli isolated from diverse clinical specimens should not be overlooked and recognized by using standard methods, to institute appropriate and timely antibiotic reporting. There is an alarmingly high rate of resistance to many antimicrobials created by the non-fermenter Gram-negative bacilli including carbapenems. We suggest that further studies should be carried out to assess the usefulness of older and newer antimicrobial agents to prevent the emergence of multi drug resistant bacteria in clinical spacimens. Literature review.
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